UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 114

Sortiert nach

ES25.04 Multiple Pulmonary Lesions: Metastasis vs Multiple Primaries, From Martini's Criteria to Molecular Profiling

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S91-S92

Thunnissen, E.

2021

Volltextzugriff (PDF)

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S985-S985

2021

Volltextzugriff (PDF)

MTE 02.01 Appropriate and Optimized Handling of Surgically Resected Specimens

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1633-S1634

Thunnissen, E.

2017

Volltextzugriff (PDF)

Inter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)

Annals of oncology, 2018-10, Vol.29, p.viii49-viii49

2018

Volltextzugriff (PDF)

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

The New England journal of medicine, 2020-02, Vol.382 (6), p.503-513

2020

Volltextzugriff (PDF)

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S325-S325

2018

Volltextzugriff (PDF)

22O REBIOPSY IN TKI-RESISTANCE: A RETROSPECTIVE ANALYSIS

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S10-S10

2013

Volltextzugriff (PDF)

3001 Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project

European journal of cancer (1990), 2015-09, Vol.51, p.S595-S596

2015

Volltextzugriff (PDF)

MA12.08 Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S87-S88

2022

Volltextzugriff (PDF)

15O VOLUMETRIC COMPUTER TOMOGRAPHY SCREENING FOR LUNG CANCER: THREE ROUNDS OF THE NELSON TRIAL

Lung cancer (Amsterdam, Netherlands), 2013-05, Vol.80, p.S7-S7

2013

Volltextzugriff (PDF)

Results of a Pilot External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non-Small Cell Lung Cancer Managed by EMQN, ESMO, ESP, and ETOP

European journal of cancer (1990), 2011, Vol.47, p.13-13

2011

Volltextzugriff (PDF)

ETOP activity in the field of biomarkers and predictors

Lung cancer (Amsterdam, Netherlands), 2012-06, Vol.77, p.S16-S17

2012

Volltextzugriff (PDF)

FP14.03 Diagnostic Accuracy in Central Pulmonary Carcinoid tumors is Dependent of Biopsy Size

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S971-S971

2021

Volltextzugriff (PDF)

PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily Practice

Value in health, 2011, Vol.14 (7), p.A463-A464

2011

Volltextzugriff (PDF)

Association of tumor and stroma PD-1, PD-L1, CD3, CD4 and CD8 expression with response to nivolumab treatment in NSCLC patients

Annals of oncology, 2017-09, Vol.28, p.v29-v29

2017

Volltextzugriff (PDF)

P66.04 A Multimodal Biomarker Predicts Dissemination of Bronchial Carcinoid

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S1193-S1193

2021

Volltextzugriff (PDF)

P2.05-03 Tumor Atelectasis Gives Rise to Solid Appearance in Pulmonary Adenocarcinomas

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S748-S748

2019

Volltextzugriff (PDF)

1390P Impact of adding viagenpumatucel-L to nivolumab in non-small cell lung cancer (NSCLC) patients with low levels of tumour infiltrating lymphocytes

Annals of oncology, 2020-09, Vol.31, p.S883-S883

2020

Volltextzugriff (PDF)

191P ROS1 fusions in resected stage I-III adenocarcinoma (ADC): A Lungscape ETOP study

Journal of thoracic oncology, 2023-04, Vol.18 (4), p.S144-S145

2023

Volltextzugriff (PDF)

P2.02-024 False Positivity Due to Polysomy in Fluorescence in Situ Hybridization

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2107-S2107

2017

Volltextzugriff (PDF)

MA12.07 Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma with Lepidic Growth

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S87

2022

Volltextzugriff (PDF)

PL03.07 Invasion or No Invasion, That’s the Question. A Large Reproducibility Study in Pulmonary Adenocarcinoma, Supporting a Modified Classification

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S35-S36

2023

Volltextzugriff (PDF)

MA03.05 New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S363-S364

2018

Volltextzugriff (PDF)

P1.04-12 Tumor Uptake and Biodistribution of 89Zr-Labeled Pembrolizumab in Patients with Metastatic Non-Small-Cell Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S443-S443

2019

Volltextzugriff (PDF)

21P Influence of delayed and prolonged fixation on the evaluation of immunohistochemical staining on pulmonary resection specimen

Journal of thoracic oncology, 2018-04, Vol.13 (4), p.S11-S11

2018

Volltextzugriff (PDF)

1 – 25 von 114

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(105)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(17)
Biological And Medical Sciences
(11)
Female
(8)
Lung Cancer
(8)
Male
(8)
Medical Sciences
(7)
Hematology, Oncology And Palliative Medicine
(5)
Adult
(4)
Animals
(4)
Diagnosis, Differential
(4)
Fundamental And Applied Biological Sciences. Psychology
(4)
Lung Neoplasms - Diagnostic Imaging
(4)
Lung Neoplasms - Pathology
(4)
Models, Molecular
(4)
Aged
(3)
Cellular Biology
(3)
Computed Tomography
(3)
Hydrogen Bonding
(3)
Immunohistochemistry
(3)
Medicin Och Hälsovetenskap
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ES25.04 Multiple Pulmonary Lesions: Metastasis vs Multiple Primaries, From Martini's Criteria to Molecular Profiling

P06.02 Incorporating Surgical Collapse in the Pathological Assessment of Resected Adenocarcinoma in situ of the Lung. A Proof of Principle Study

MTE 02.01 Appropriate and Optimized Handling of Surgically Resected Specimens

Inter-rater reliability of programmed death ligand 1 (PD-L1) scoring using the VENTANA PD-L1 (SP263) assay in non-small cell lung cancer (NSCLC)

Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

OA03.03 Phase 2B of Blueprint PD-L1 Immunohistochemistry Assay Comparability Study

22O REBIOPSY IN TKI-RESISTANCE: A RETROSPECTIVE ANALYSIS

3001 Prevalence and clinical association of gene mutations through Multiplex Mutation Testing in patients with NSCLC: Results from the ETOP Lungscape Project

MA12.08 Pagetoid Growth of Squamous Cell Carcinoma with a Subsolid Component

15O VOLUMETRIC COMPUTER TOMOGRAPHY SCREENING FOR LUNG CANCER: THREE ROUNDS OF THE NELSON TRIAL

Results of a Pilot External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non-Small Cell Lung Cancer Managed by EMQN, ESMO, ESP, and ETOP

ETOP activity in the field of biomarkers and predictors

FP14.03 Diagnostic Accuracy in Central Pulmonary Carcinoid tumors is Dependent of Biopsy Size

PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily Practice

Association of tumor and stroma PD-1, PD-L1, CD3, CD4 and CD8 expression with response to nivolumab treatment in NSCLC patients

P66.04 A Multimodal Biomarker Predicts Dissemination of Bronchial Carcinoid

P2.05-03 Tumor Atelectasis Gives Rise to Solid Appearance in Pulmonary Adenocarcinomas

1390P Impact of adding viagenpumatucel-L to nivolumab in non-small cell lung cancer (NSCLC) patients with low levels of tumour infiltrating lymphocytes

191P ROS1 fusions in resected stage I-III adenocarcinoma (ADC): A Lungscape ETOP study

P2.02-024 False Positivity Due to Polysomy in Fluorescence in Situ Hybridization

MA12.07 Defining Morphologic Features of Invasion in Pulmonarynon-Mucinousadenocarcinoma with Lepidic Growth

PL03.07 Invasion or No Invasion, That’s the Question. A Large Reproducibility Study in Pulmonary Adenocarcinoma, Supporting a Modified Classification

MA03.05 New Subsolid Pulmonary Nodules in Lung Cancer Screening: The NELSON Trial

P1.04-12 Tumor Uptake and Biodistribution of 89Zr-Labeled Pembrolizumab in Patients with Metastatic Non-Small-Cell Lung Cancer

21P Influence of delayed and prolonged fixation on the evaluation of immunohistochemical staining on pulmonary resection specimen

Aktive Filter

Suchergebnisse filtern